Correlation Between Arbutus Biopharma and Adaptimmune Therapeutics
Can any of the company-specific risk be diversified away by investing in both Arbutus Biopharma and Adaptimmune Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arbutus Biopharma and Adaptimmune Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arbutus Biopharma Corp and Adaptimmune Therapeutics Plc, you can compare the effects of market volatilities on Arbutus Biopharma and Adaptimmune Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arbutus Biopharma with a short position of Adaptimmune Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arbutus Biopharma and Adaptimmune Therapeutics.
Diversification Opportunities for Arbutus Biopharma and Adaptimmune Therapeutics
0.74 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Arbutus and Adaptimmune is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Arbutus Biopharma Corp and Adaptimmune Therapeutics Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adaptimmune Therapeutics and Arbutus Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arbutus Biopharma Corp are associated (or correlated) with Adaptimmune Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adaptimmune Therapeutics has no effect on the direction of Arbutus Biopharma i.e., Arbutus Biopharma and Adaptimmune Therapeutics go up and down completely randomly.
Pair Corralation between Arbutus Biopharma and Adaptimmune Therapeutics
Given the investment horizon of 90 days Arbutus Biopharma Corp is expected to generate 0.52 times more return on investment than Adaptimmune Therapeutics. However, Arbutus Biopharma Corp is 1.91 times less risky than Adaptimmune Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Adaptimmune Therapeutics Plc is currently generating about -0.03 per unit of risk. If you would invest 249.00 in Arbutus Biopharma Corp on November 3, 2024 and sell it today you would earn a total of 81.00 from holding Arbutus Biopharma Corp or generate 32.53% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 99.6% |
| Values | Daily Returns |
Arbutus Biopharma Corp vs. Adaptimmune Therapeutics Plc
Performance |
| Timeline |
| Arbutus Biopharma Corp |
| Adaptimmune Therapeutics |
Arbutus Biopharma and Adaptimmune Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Arbutus Biopharma and Adaptimmune Therapeutics
The main advantage of trading using opposite Arbutus Biopharma and Adaptimmune Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arbutus Biopharma position performs unexpectedly, Adaptimmune Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adaptimmune Therapeutics will offset losses from the drop in Adaptimmune Therapeutics' long position.| Arbutus Biopharma vs. ADMA Biologics | Arbutus Biopharma vs. Adaptimmune Therapeutics Plc | Arbutus Biopharma vs. Affimed NV | Arbutus Biopharma vs. Corvus Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |